(Q53161943)

12 May 2018

title

Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells. (English)

1 reference

12 May 2018

0 references

Yu-Jia Chang

10

0 references

author name string

Chin-Sheng Hung

1

1 reference

12 May 2018

Hui-Hsiung Liu

2

1 reference

12 May 2018

Ming-Te Huang

3

1 reference

12 May 2018

Chao-Wen Cheng

4

1 reference

12 May 2018

Li-Jen Kuo

5

1 reference

12 May 2018

Yuan-Soon Ho

6

1 reference

12 May 2018

Chih-Hsiung Wu

7

1 reference

12 May 2018

Chien-Ming Chen

8

1 reference

12 May 2018

Po-Li Wei

9

1 reference

12 May 2018

publication date

19 June 2012

1 reference

12 May 2018

Annals of Surgical Oncology

published in

1 reference

12 May 2018

volume

19

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

3547-3555

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-012-2393-4

exact match

0 references

cites work

Focus on hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Hepatocellular carcinoma: the need for progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Major achievements in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

The Survivin saga goes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Modulation of transcription factors by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Curcumin for chemoprevention of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

Her2-positive breast cancer: herceptin and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2393-4

10.1245/S10434-012-2393-4

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

Dimensions Publication ID

1036456530

0 references

1 reference

12 May 2018